Home » Topics » Regulatory

Regulatory
RSS

FDA approves Mozobil to mobilize hematopoietic stem cells in transplantation

Dec. 17, 2008

FDA approves Abbott's Trilipix for patients with mixed dyslipidemia

Dec. 17, 2008

Stelara approved in Canada for moderate to severe plaque psoriasis

Dec. 17, 2008

FDA approves Pegintron/Rebetol combination in pediatric HCV patients

Dec. 16, 2008

FDA approves Lusedra for sedation in diagnostic or therapeutic procedures

Dec. 15, 2008

FDA approves tapentadol immediate-release tablets for acute pain

Nov. 24, 2008

Pirfenidone approved in Japan for idiopathic pulmonary fibrosis

Oct. 20, 2008

FDA grants marketing approval to Boston Scientific's Taxus Liberte paclitaxel-eluting stent

Oct. 14, 2008

Lev receives FDA approval for Cinryze in hereditary angioedema prophylaxis

Oct. 13, 2008

FDA approves Bayer HealthCare's Kogenate for prophylaxis in hemophilia A

Oct. 13, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...